Lilly launches first dog drug

Share this article:
Eli Lilly has launched its first prescription drug for pets in the US, a beef flavored chewable tablet that helps treat dogs for separation anxiety. The drug, marketed under the name Reconcile, uses the same compound as Lilly’s blockbuster antidepressant Prozac. Reconcile is designed to be used in combination with behavior management training to help dogs that have difficulty being separated from their owner or family members. “It basically calms the dog and makes it more receptive to the training that’s supposed to go along with it,” Lilly veterinarian Steve Connell, told the Associated Press. Revenue projections and pricing for Reconcile were not made available. Reconcile has one competitor on the market Clomicalm, which is made my Novartis.
Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.